Coherus Oncology Inc
(CHRS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 28,507 | -237,892 | -291,754 | -287,100 | 132,244 |
| Depreciation Amortization | 5,276 | 3,791 | 3,699 | 3,454 | 2,888 |
| Accounts receivable | 149,350 | -150,683 | 13,052 | 34,062 | -15,218 |
| Accounts payable and accrued liabilities | -3,938 | 23,760 | -4,548 | 874 | -9,820 |
| Other Working Capital | 57,288 | -34,350 | -76,754 | 44,567 | -34,651 |
| Other Operating Activity | -256,923 | 220,490 | 115,181 | 166,711 | 78,702 |
| Operating Cash Flow | $-20,440 | $-174,884 | $-241,124 | $-37,432 | $154,145 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -1,289 | -7,231 |
| Net Acquisitions | N/A | 6,997 | N/A | N/A | 175 |
| Purchase Of Investment | 0 | -19,507 | -127,382 | -182,485 | -273,845 |
| Sale Of Investment | 14,888 | 157,642 | 0 | 181,364 | 274,000 |
| Other Investing Activity | 215,433 | -492 | -39,468 | -136,000 | -7,500 |
| Investing Cash Flow | $230,321 | $144,640 | $-166,850 | $-138,410 | $-14,401 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 36,979 | N/A | 240,679 | N/A | 222,156 |
| Debt Repayment | -260,387 | 0 | -190,750 | N/A | -18,170 |
| Common Stock Issued | 1,746 | 72,412 | 7,049 | 54,304 | 17,428 |
| Common Stock Repurchased | 926 | 1,809 | 2,320 | N/A | 3,801 |
| Other Financing Activity | 33,762 | -4,621 | -4,972 | -2,425 | -1,269 |
| Financing Cash Flow | $-186,974 | $69,600 | $54,326 | $51,879 | $223,946 |
| Beginning Cash Position | 103,343 | 63,987 | 417,635 | 541,598 | 177,908 |
| End Cash Position | 126,250 | 103,343 | 63,987 | 417,635 | 541,598 |
| Net Cash Flow | $22,907 | $39,356 | $-353,648 | $-123,963 | $363,690 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,440 | -174,884 | -241,124 | -37,432 | 154,145 |
| Capital Expenditure | N/A | N/A | N/A | -1,289 | -7,231 |
| Free Cash Flow | -20,440 | -174,884 | -241,124 | -38,721 | 146,914 |